泛微網絡(603039.SH)獲李鳳英舉牌 持股達5.034%
格隆匯3月16日丨泛微網絡(603039.SH)公佈,公司於近日收到公司股東李鳳英發來的《上海泛微網絡科技股份有限公司簡式權益變動報告書》,本次權益變動前,李鳳英持有公司758.14萬股股份,占上市公司總股本約4.9996%。李鳳英通過集中競價交易的方式累計增持公司二級市場流通的股份,增持5.2136萬股。
本次權益變動後,李鳳英所持上市公司無限售條件流通股763.35萬股,佔公司總股本的比例為5.0340%,成為公司持股5%以上股東。所有股份均享有表決權,不存在表決權委託或受限的情況。其中378.28萬股處於質押狀態,存在被限制轉讓的情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.